Hosted on MSN12d
Long-acting injectable HIV therapy offers hope for those unable to take pills
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...
The American Journal of Managed Care6d
Long-Acting Injectable Cabotegravir Effective in Both ART, PrEP
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...
BioSpace6d
Gilead, GSK-ViiV Move Ahead With Long-Acting HIV Options Following Early-Stage Readouts
Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...
Managed Healthcare Executive5d
New Generation of Long-Acting Antiretrovirals Shows Promise
The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...
Healio4d
Long-acting treatment benefits postpartum women with HIV and their babies
Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...
Medscape11y
Perils and Pitfalls of Long-term Effects of Proton Pump Inhibitors
[40] Patients may be at higher risk of developing fractures and this may be related to the dose or the duration of use of PPIs. If long-term PPI therapy is to be used, monitoring of bone density ...